Advertisement

Tumors of the Salivary Gland

  • Diana Bell
  • Michelle D. Williams
  • Adel K. El-NaggarEmail author
Chapter
  • 630 Downloads

Abstract

Recent advances in the diagnosis, differential diagnostics, and salient features of clinical relevance are concisely presented in this chapter. The role of fine needle aspiration and the limitations of this procedure in presurgical management of patients with these tumors are emphasized in communicating findings to clinicians. Similarly, the utilization of lineage-associated markers in the diagnosis and differential diagnosis of salivary and non-salivary tumors is tailored to emphasize context association. In this chapter, verified and consistent molecular and genetic findings are presented for familiarity and for their potential clinical and therapeutic implications. Emphasis on the future integration of these findings in current diagnosis and management remains to be validated.

Keywords

Salivary neoplasms Benign neoplasms Salivary tumor classification Biomarkers Genetic alternatives Lineage-related markers High-grade transformation 

References

  1. 1.
    Ellis GL. What’s new in the AFIP fascicle on salivary gland tumors: a few highlights from the 4th series atlas. Head Neck Pathol. 2009;3(3):225–30.PubMedPubMedCentralGoogle Scholar
  2. 2.
    El-Naggar AK, Chan JKC, Takata T, Grandis JR, Slootweg PJ. The fourth edition of the head and neck World Health Organization blue book: editors’ perspectives. Hum Pathol. 2017;66:10–2.PubMedGoogle Scholar
  3. 3.
    Bradley PJ, Eisele DW. Salivary gland neoplasms in children and adolescents. Adv Otorhinolaryngol. 2016;78:175–81.PubMedGoogle Scholar
  4. 4.
    Kupferman ME, de la Garza GO, Santillan AA, et al. Outcomes of pediatric patients with malignancies of the major salivary glands. Ann Surg Oncol. 2010;17(12):3301–7.PubMedGoogle Scholar
  5. 5.
    Mehta D, Willging JP. Pediatric salivary gland lesions. Semin Pediatr Surg. 2006;15(2):76–84.PubMedGoogle Scholar
  6. 6.
    Yoshida EJ, Garcia J, Eisele DW, Chen AM. Salivary gland malignancies in children. Int J Pediatr Otorhinolaryngol. 2014;78(2):174–8.PubMedGoogle Scholar
  7. 7.
    Madani SZ, Jalayernaderi N, Merati M, Haghshenas H, Ashouri M. Accuracy of fine needle aspiration (FNA) in diagnosis of major salivary gland tumors. Res J Med Sci. 2011;5(2).Google Scholar
  8. 8.
    Mairembam P, Jay A, Beale T, et al. Salivary gland FNA cytology: role as a triage tool and an approach to pitfalls in cytomorphology. Cytopathology. 2016;27(2):91–6.PubMedGoogle Scholar
  9. 9.
    Rohilla M, Singh P, Rajwanshi A, et al. Three-year cytohistological correlation of salivary gland FNA cytology at a tertiary center with the application of the Milan system for risk stratification. Cancer. 2017;125(10):767–75.Google Scholar
  10. 10.
    Triantafyllou A, Thompson LD, Devaney KO, et al. Functional histology of salivary gland pleomorphic adenoma: an appraisal. Head Neck Pathol. 2015;9(3):387–404.PubMedGoogle Scholar
  11. 11.
    Bell D, Myers JN, Rao PH, El-Naggar AK. t(3;8) as the sole chromosomal abnormality in a myoepithelial carcinoma ex pleomorphic adenoma: a putative progression event. Head Neck. 2013;35(6):E181–3.PubMedGoogle Scholar
  12. 12.
    Roijer E, Kas K, Van de Ven W, Stenman G. Mapping of the 8q12 translocation breakpoint to a 40-kb region in a pleomorphic adenoma with an ins(8;3)(q12;p21.3p14.1). Cytogenet Cell Genet. 1997;76(1–2):23–6.PubMedGoogle Scholar
  13. 13.
    Stenman G, Sahlin P, Mark J, Chaganti RS, Kindblom LG, Aman P. The 12q13-q15 translocation breakpoints in pleomorphic adenoma and clear-cell sarcoma of tendons and aponeuroses are different from that in myxoid liposarcoma. Genes Chromosomes Cancer. Jul 1993;7(3):178–80.PubMedGoogle Scholar
  14. 14.
    Katabi N, Ghossein R, Ho A, et al. Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts. Hum Pathol. 2015;46(1):26–33.PubMedGoogle Scholar
  15. 15.
    Matsuyama A, Hisaoka M, Nagao Y, Hashimoto H. Aberrant PLAG1 expression in pleomorphic adenomas of the salivary gland: a molecular genetic and immunohistochemical study. Virchows Arch. 2011;458(5):583–92.PubMedGoogle Scholar
  16. 16.
    Mito JK, Jo VY, Chiosea SI, Dal Cin P, Krane JF. HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma. Histopathology. 2017;71(4):511–21.PubMedGoogle Scholar
  17. 17.
    Bell D, Luna MA, Weber RS, Kaye FJ, El-Naggar AK. CRTC1/MAML2 fusion transcript in Warthin’s tumor and mucoepidermoid carcinoma: evidence for a common genetic association. Genes Chromosomes Cancer. 2008;47(4):309–14.PubMedGoogle Scholar
  18. 18.
    Tirado Y, Williams MD, Hanna EY, Kaye FJ, Batsakis JG, El-Naggar AK. CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior. Genes Chromosomes Cancer. 2007;46(7):708–15.PubMedGoogle Scholar
  19. 19.
    Martins C, Fonseca I, Roque L, Soares J. Cytogenetic characterisation of Warthin's tumour. Oral Oncol. 1997;33(5):344–7.PubMedGoogle Scholar
  20. 20.
    Nordkvist A, Mark J, Dahlenfors R, Bende M, Stenman G. Cytogenetic observations in 13 cystadenolymphomas (Warthin’s tumors). Cancer Genet Cytogenet. 1994;76(2):129–35.PubMedGoogle Scholar
  21. 21.
    Batsakis JG, Luna MA, El-Naggar AK. Basaloid monomorphic adenomas. Ann Otol Rhinol Laryngol. 1991;100(8):687–90.PubMedGoogle Scholar
  22. 22.
    Choi HR, Batsakis JG, Callender DL, Prieto VG, Luna MA, El-Naggar AK. Molecular analysis of chromosome 16q regions in dermal analogue tumors of salivary glands: a genetic link to dermal cylindroma? Am J Surg Pathol. 2002;26(6):778–83.PubMedGoogle Scholar
  23. 23.
    Jo VY, Sholl LM, Krane JF. Distinctive patterns of CTNNB1 (beta-catenin) alterations in salivary gland basal cell adenoma and basal cell adenocarcinoma. Am J Surg Pathol. 2016;40(8):1143–50.PubMedGoogle Scholar
  24. 24.
    Kazakov DV, Zelger B, Rutten A, et al. Morphologic diversity of malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma based on the study of 24 cases, sporadic or occurring in the setting of Brooke-Spiegler syndrome. Am J Surg Pathol. 2009;33(5):705–19.PubMedPubMedCentralGoogle Scholar
  25. 25.
    Thompson LD, Bauer JL, Chiosea S, et al. Canalicular adenoma: a clinicopathologic and immunohistochemical analysis of 67 cases with a review of the literature. Head Neck Pathol. 2015;9(2):181–95.PubMedGoogle Scholar
  26. 26.
    Nagel H, Laskawi R, Eiffert H, Schlott T. Analysis of the tumour suppressor genes, FHIT and WT-1, and the tumour rejection genes, BAGE, GAGE-1/2, HAGE, MAGE-1, and MAGE-3, in benign and malignant neoplasms of the salivary glands. Mol Pathol. 2003;56(4):226–31.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Bell D, El-Naggar AK. Molecular heterogeneity in mucoepidermoid carcinoma: conceptual and practical implications. Head Neck Pathol. 2013;7(1):23–7.PubMedPubMedCentralGoogle Scholar
  28. 28.
    Tonon G, Modi S, Wu L, et al. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nat Genet. 2003;33(2):208–13.PubMedPubMedCentralGoogle Scholar
  29. 29.
    Anzick SL, Chen WD, Park Y, et al. Unfavorable prognosis of CRTC1-MAML2 positive mucoepidermoid tumors with CDKN2A deletions. Genes Chromosomes Cancer. 2010;49(1):59–69.PubMedPubMedCentralGoogle Scholar
  30. 30.
    Griffith CC, Thompson LD, Assaad A, et al. Salivary duct carcinoma and the concept of early carcinoma ex pleomorphic adenoma. Histopathology. 2014;65(6):854–60.PubMedGoogle Scholar
  31. 31.
    Udager AM, Chiosea SI. Salivary duct carcinoma: an update on morphologic mimics and diagnostic use of androgen receptor immunohistochemistry. Head Neck Pathol. 2017;11(3):288–94.PubMedPubMedCentralGoogle Scholar
  32. 32.
    Williams MD, Roberts D, Blumenschein GR Jr, et al. Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients. Am J Surg Pathol. 2007;31(11):1645–52.PubMedGoogle Scholar
  33. 33.
    Mitani Y, Rao PH, Maity SN, et al. Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications. Clin Cancer Res. 2014;20(24):6570–81.PubMedPubMedCentralGoogle Scholar
  34. 34.
    Williams L, Thompson LD, Seethala RR, et al. Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression. Am J Surg Pathol. 2015;39(5):705–13.PubMedGoogle Scholar
  35. 35.
    Williams MD, Roberts DB, Kies MS, Mao L, Weber RS, El-Naggar AK. Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance. Clin Cancer Res. 2010;16(8):2266–74.PubMedPubMedCentralGoogle Scholar
  36. 36.
    Fehr A, Kovacs A, Loning T, Frierson H Jr, van den Oord J, Stenman G. The MYB-NFIB gene fusion-a novel genetic link between adenoid cystic carcinoma and dermal cylindroma. J Pathol. 2011;224(3):322–7.PubMedGoogle Scholar
  37. 37.
    Mitani Y, Rao PH, Futreal PA, et al. Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome. Clin Cancer Res. 2011;17(22):7003–14.PubMedPubMedCentralGoogle Scholar
  38. 38.
    Nordkvist A, Mark J, Gustafsson H, Bang G, Stenman G. Non-random chromosome rearrangements in adenoid cystic carcinoma of the salivary glands. Genes Chromosomes Cancer. 1994;10(2):115–21.PubMedGoogle Scholar
  39. 39.
    Rutherford S, Yu Y, Rumpel CA, Frierson HF Jr, Moskaluk CA. Chromosome 6 deletion and candidate tumor suppressor genes in adenoid cystic carcinoma. Cancer Lett. 2006;236(2):309–17.PubMedGoogle Scholar
  40. 40.
    Thompson LD, Aslam MN, Stall JN, Udager AM, Chiosea S, McHugh JB. Clinicopathologic and immunophenotypic characterization of 25 cases of acinic cell carcinoma with high-grade transformation. Head Neck Pathol. 2016;10(2):152–60.PubMedGoogle Scholar
  41. 41.
    El-Naggar AK, Abdul-Karim FW, Hurr K, Callender D, Luna MA, Batsakis JG. Genetic alterations in acinic cell carcinoma of the parotid gland determined by microsatellite analysis. Cancer Genet Cytogenet. 1998;102(1):19–24.PubMedGoogle Scholar
  42. 42.
    Skalova A, Sima R, Vanecek T, et al. Acinic cell carcinoma with high-grade transformation: a report of 9 cases with immunohistochemical study and analysis of TP53 and HER-2/neu genes. Am J Surg Pathol. 2009;33(8):1137–45.PubMedGoogle Scholar
  43. 43.
    Skalova A. Mammary analogue secretory carcinoma of salivary gland origin: an update and expanded morphologic and immunohistochemical spectrum of recently described entity. Head Neck Pathol. 2013;7(Suppl 1):S30–6.PubMedGoogle Scholar
  44. 44.
    Skalova A, Vanecek T, Majewska H, et al. Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, beta-catenin, EGFR, and CCND1 genes. Am J Surg Pathol. 2014;38(1):23–33.PubMedGoogle Scholar
  45. 45.
    Skalova A, Vanecek T, Sima R, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34(5):599–608.PubMedGoogle Scholar
  46. 46.
    Urano M, Nagao T, Miyabe S, Ishibashi K, Higuchi K, Kuroda M. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers. Hum Pathol. 2015;46(1):94–103.PubMedGoogle Scholar
  47. 47.
    Evans HL, Luna MA. Polymorphous low-grade adenocarcinoma: a study of 40 cases with long-term follow up and an evaluation of the importance of papillary areas. Am J Surg Pathol. 2000;24(10):1319–28.PubMedGoogle Scholar
  48. 48.
    Xu B, Aneja A, Ghossein R, Katabi N. Predictors of outcome in the phenotypic Spectrum of polymorphous low-grade adenocarcinoma (PLGA) and cribriform adenocarcinoma of salivary gland (CASG): a retrospective study of 69 patients. Am J Surg Pathol. 2016;40(11):1526–37.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Diana Bell
    • 1
  • Michelle D. Williams
    • 1
  • Adel K. El-Naggar
    • 1
    Email author
  1. 1.Department of PathologyUniversity of Texas M.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations